斋月期间的抗精神病药物治疗:文献综述

Y. Alomi, Jude Alhowaidi, Raneem Alzeer, Ali Alhowaidi, Nora Alhowaidi
{"title":"斋月期间的抗精神病药物治疗:文献综述","authors":"Y. Alomi, Jude Alhowaidi, Raneem Alzeer, Ali Alhowaidi, Nora Alhowaidi","doi":"10.5530/PTB.2019.5.14","DOIUrl":null,"url":null,"abstract":"Objectives: To review the antipsychotic medication therapy during the holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. The search on antipsychotic and anti-epileptic medication list and switch from regular days to Ramadan days included comparative safety, efficacy and cost of type of medication for each disease and national or international evidence-based guidelines including those switching short half-life to long half-life drugs. All nonoral dosage form of medication will be excluded in this study. All medications should be documented in the Ministry of Health drug formulary. Results: A total of 710 studies were shortlisted after an extensive search with specific terms. Of those, 104 studies were duplicate studies; therefore only 606 studies were included for further evaluation. The evaluation revealed that 27 studies discussed about the antipsy- chotic medications and Ramadan. Of these, only five were appropriate for further revision. According to our results, most of the studies were observational studies and a few have conducted experimental design studies. Three studies have a shared or similar study design (i.e., reports). Among all the reports analyzed in this study, most of them used study design. On the contrary, three studies mentioned the utilization of a descriptive approach; however, none of the studies mentioned the exact type of descriptive analysis conducted. One study was a clinical review and another study mentioned the applicability of a randomized controlled trial. Based on this, the authors suggested switching the antipsychotic and anti-epileptic medication from regular days to Ramadan days. Conclusion: There are no randomized clinical trials in the literature to validate the switching of medication from regular to Ramadan days. A list of antipsychotic medications that can be used to switch during Ramadan is highly warranted. Further studies to validate the medication used to treat psychiatric conditions during the holy month of Ramadan is recommended. Antipsychotic, Medication, Therapy, Review.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antipsychotic medication therapy during the holy month of Ramadan: a literature review\",\"authors\":\"Y. Alomi, Jude Alhowaidi, Raneem Alzeer, Ali Alhowaidi, Nora Alhowaidi\",\"doi\":\"10.5530/PTB.2019.5.14\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: To review the antipsychotic medication therapy during the holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. The search on antipsychotic and anti-epileptic medication list and switch from regular days to Ramadan days included comparative safety, efficacy and cost of type of medication for each disease and national or international evidence-based guidelines including those switching short half-life to long half-life drugs. All nonoral dosage form of medication will be excluded in this study. All medications should be documented in the Ministry of Health drug formulary. Results: A total of 710 studies were shortlisted after an extensive search with specific terms. Of those, 104 studies were duplicate studies; therefore only 606 studies were included for further evaluation. The evaluation revealed that 27 studies discussed about the antipsy- chotic medications and Ramadan. Of these, only five were appropriate for further revision. According to our results, most of the studies were observational studies and a few have conducted experimental design studies. Three studies have a shared or similar study design (i.e., reports). Among all the reports analyzed in this study, most of them used study design. On the contrary, three studies mentioned the utilization of a descriptive approach; however, none of the studies mentioned the exact type of descriptive analysis conducted. One study was a clinical review and another study mentioned the applicability of a randomized controlled trial. Based on this, the authors suggested switching the antipsychotic and anti-epileptic medication from regular days to Ramadan days. Conclusion: There are no randomized clinical trials in the literature to validate the switching of medication from regular to Ramadan days. A list of antipsychotic medications that can be used to switch during Ramadan is highly warranted. Further studies to validate the medication used to treat psychiatric conditions during the holy month of Ramadan is recommended. Antipsychotic, Medication, Therapy, Review.\",\"PeriodicalId\":416050,\"journal\":{\"name\":\"Pharmacology, Toxicology and Biomedical Reports\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacology, Toxicology and Biomedical Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5530/PTB.2019.5.14\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology, Toxicology and Biomedical Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/PTB.2019.5.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:回顾斋月期间的抗精神病药物治疗。方法:在本研究中,我们通过沙特数字图书馆搜索引擎对50个数据库进行了广泛的搜索。我们纳入了2017年5月以英语发表的荟萃分析、随机对照研究和观察性研究。搜索词包括斋月、禁食、药物、治疗、疾病类型和基于治疗类别的药物。对抗精神病和抗癫痫药物清单的搜索,以及从常规日到斋月日的转换,包括每种疾病的药物类型的相对安全性、有效性和成本,以及国家或国际循证指南,包括将短半衰期药物转换为长半衰期药物的指南。所有非口服剂型的药物将被排除在本研究之外。所有药物都应记录在卫生部药物处方中。结果:在广泛搜索特定术语后,共有710项研究入围。其中,104项研究是重复研究;因此,仅纳入606项研究进行进一步评价。评价结果显示,27项研究讨论了抗精神病药物与斋月的关系。其中,只有五个适合作进一步修订。根据我们的研究结果,大多数研究是观察性研究,少数研究进行了实验设计研究。三个研究具有共享或相似的研究设计(即报告)。在本研究分析的所有报告中,大多数采用了研究设计。相反,有三项研究提到使用描述性方法;然而,没有一项研究提到所进行的描述性分析的确切类型。一项研究是临床回顾,另一项研究提到了随机对照试验的适用性。基于此,作者建议将抗精神病和抗癫痫药物从正常的日子改为斋月的日子。结论:文献中没有随机临床试验来验证从常规到斋月用药的转换。一份抗精神病药物的清单可以用来在斋月期间转换,这是非常有道理的。建议进行进一步的研究,以验证在斋月期间用于治疗精神疾病的药物。抗精神病药,药物,治疗,回顾。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antipsychotic medication therapy during the holy month of Ramadan: a literature review
Objectives: To review the antipsychotic medication therapy during the holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. The search on antipsychotic and anti-epileptic medication list and switch from regular days to Ramadan days included comparative safety, efficacy and cost of type of medication for each disease and national or international evidence-based guidelines including those switching short half-life to long half-life drugs. All nonoral dosage form of medication will be excluded in this study. All medications should be documented in the Ministry of Health drug formulary. Results: A total of 710 studies were shortlisted after an extensive search with specific terms. Of those, 104 studies were duplicate studies; therefore only 606 studies were included for further evaluation. The evaluation revealed that 27 studies discussed about the antipsy- chotic medications and Ramadan. Of these, only five were appropriate for further revision. According to our results, most of the studies were observational studies and a few have conducted experimental design studies. Three studies have a shared or similar study design (i.e., reports). Among all the reports analyzed in this study, most of them used study design. On the contrary, three studies mentioned the utilization of a descriptive approach; however, none of the studies mentioned the exact type of descriptive analysis conducted. One study was a clinical review and another study mentioned the applicability of a randomized controlled trial. Based on this, the authors suggested switching the antipsychotic and anti-epileptic medication from regular days to Ramadan days. Conclusion: There are no randomized clinical trials in the literature to validate the switching of medication from regular to Ramadan days. A list of antipsychotic medications that can be used to switch during Ramadan is highly warranted. Further studies to validate the medication used to treat psychiatric conditions during the holy month of Ramadan is recommended. Antipsychotic, Medication, Therapy, Review.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信